Premium
Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome
Author(s) -
Zolota Vassiliki,
Tsamandas Athanassios C.,
Aroukatos Panagiotis,
Panagiotopoulos Vassilios,
Maraziotis Theodore,
Poulos Constantinos,
Scopa Chrisoula D.
Publication year - 2008
Publication title -
neuropathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 61
eISSN - 1440-1789
pISSN - 0919-6544
DOI - 10.1111/j.1440-1789.2007.00844.x
Subject(s) - glioma , medicine , immunohistochemistry , ki 67 , cell cycle , proportional hazards model , oncology , proliferative index , proliferation index , correlation , pathology , cancer research , cancer , geometry , mathematics
Gliomas are among the most aggressive and treatment‐refractory of all human tumors. The aim of the present study is to evaluate the role of the expression of cell cycle molecules as prognostic indicators in gliomas. We immunohistochemically analyzed the expression of p21, p27, p14, p16, p53 and proliferation marker Ki67, in 67 low and high grade astrocytic tumors. High grade tumors exhibited higher labeling indices for Ki67 ( P = 0.004), p53 ( P = 0.039) and slightly higher index for p21 ( P = 0.07) compared to low grade tumors. p14 and p16 were more frequently present in low grade tumors ( P = 0.001 and P = 0.052, respectively). Worse survival was correlated with high grade tumors ( P < 0.0001) and higher Ki67 index ( P < 0.0001). Cox regression analysis revealed that only age, grade and marginally Ki67 index were independent prognostic factors. Cell cycle alterations are involved in the malignant progression of astrocytomas, but only age, tumor grade and proliferating index can predict the outcome of the patients with glioma.